Yeray Peñate

5PUBLICATIONS
24CO-AUTHORS
Haematological tumoursAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 11, 2025
Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study.

Lía Bejarano, Mercè Grau-Pérez, Marina Paíno-Román

|Sep 27, 2022
Anaplastic large cell lymphoma at the SARS-CoV2 vaccine injection site.

Laura Revenga-Porcel, Yeray Peñate, Francisco Granados-Pacheco

|Aug 26, 2022
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry.

Cristina Muniesa, Fernando Gallardo, Ignacio García-Doval

|Apr 20, 2022
An aggressive case of EBV-positive mucocutaneous ulcer in the female genital area; successful response to rituximab.

Laura Rodríguez-Lago, Yeray Peñate, María Teresa Marrero-Quintana

|Jun 01, 2021
Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.

A Sánchez-Velázquez, A Bauer-Alonso, T Estrach

Pageof 1

Frequent Collaborators

3 joint publications

Ricardo Fernández-de-Misa

2 joint publications

Javier Cañueto

2 joint publications

Helena Iznardo

2 joint publications

Octavio Servitje